Friday, July 31, 2026

KDDF Chief Calls for Structural Shift in Korea Biotech Beyond Technology Transfer

Dr. Park Young-min urges South Korea's biotech sector to shift from tech transfer to global collaboration for sustainable growth.

Samyang’s 3S Sugar Reduction Solution: A Game-Changer for Food Developers—Save Time and Costs in 2026

Samyang Corporation showcases AI-driven sugar reduction solutions at NPEW 2023, aiming to enhance its global market presence.

NVIDIA’s Blackwell RTX PRO 6000: 5x Faster AI Inference Coming in May

NVIDIA unveils the RTX PRO 6000 Blackwell Server Edition, enhancing AI and graphics performance with improvements over its predecessor.

Tag: GLP-1

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

Novo Nordisk’s Oral Wegovy Tops 3,000 Prescriptions in Its First Week—A Challenge to Injectable GLP-1s

Novo Nordisk's Wegovy oral treatment exceeds 3,000 prescriptions in its debut week, signaling a shift towards oral obesity medications.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Patches, Implants, and Oral Films… The Drug-Delivery Format Battle After Oral Wegovy

Oral Wegovy's launch is transforming obesity treatment, focusing on user-friendly delivery methods and enhancing patient adherence.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.